SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-055595
Filing Date
2023-12-01
Accepted
2023-12-01 07:11:59
Documents
4
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 PRE 14A edge20015072x1_pre14a.htm PRE 14A 462840
2 edge20015072x1_pcimg001.jpg GRAPHIC 142451
3 edge20015072x1_pcimg002.jpg GRAPHIC 201880
4 edge20015072x1_pre14aimg001.jpg GRAPHIC 13319
  Complete submission text file 0001140361-23-055595.txt   956880
Mailing Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38473 | Film No.: 231457520
SIC: 2834 Pharmaceutical Preparations